wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34973743-4AA49CC4-EB6B-49F5-8C9C-557B04EA3F65
Q34973743-4AA49CC4-EB6B-49F5-8C9C-557B04EA3F65
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973743-4AA49CC4-EB6B-49F5-8C9C-557B04EA3F65
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor.
P2860
Q34973743-4AA49CC4-EB6B-49F5-8C9C-557B04EA3F65
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973743-4AA49CC4-EB6B-49F5-8C9C-557B04EA3F65
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7fa3219796080c6da8feeff2d81b93bfdfe09b83
P2860
Interaction between bevacizumab and murine VEGF-A: a reassessment.